KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Return on Invested Capital (2017 - 2025)

Biomarin Pharmaceutical's Return on Invested Capital history spans 15 years, with the latest figure at 0.05% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital fell 2.0% year-over-year to 0.05%, compared with a TTM value of 0.05% through Dec 2025, down 2.0%, and an annual FY2025 reading of 0.05%, down 2.0% over the prior year.
  • Return on Invested Capital for Q4 2025 was 0.05% at Biomarin Pharmaceutical, down from 0.08% in the prior quarter.
  • The five-year high for Return on Invested Capital was 0.2% in Q2 2021, with the low at 0.02% in Q4 2021.
  • Average Return on Invested Capital over 5 years is 0.05%, with a median of 0.03% recorded in 2022.
  • Biggest YoY gain for Return on Invested Capital was 16bps in 2021; the steepest drop was -19bps in 2021.
  • Tracing BMRN's Return on Invested Capital over 5 years: stood at 0.02% in 2021, then soared by 304bps to 0.03% in 2022, then dropped by -4bps to 0.03% in 2023, then skyrocketed by 116bps to 0.07% in 2024, then dropped by -29bps to 0.05% in 2025.
  • Per Business Quant, the three most recent readings for BMRN's Return on Invested Capital are 0.05% (Q4 2025), 0.08% (Q3 2025), and 0.1% (Q2 2025).